Can a Kidney Transplant Drug Keep You from Aging?

May 1, 2023

(Wall Street Journal) – A kidney transplant drug has become the latest fixation of people trying to fight aging. Some people looking to extend their lifespan have for years turned to a decades-old diabetes drug, metformin. Now, rapamycin, an immunosuppressant medication, is capturing their attention because some aging researchers believe it holds more promise.

Rapamycin was originally approved by the U.S. Food and Drug Administration to prevent organ rejection in kidney transplant patients. Scientists have studied its potential to fight aging, too, and animal studies of rapamycin have yielded encouraging results, although there is little evidence of its longevity benefits in humans.  (Read More)